Telix Directors Report Separate On-Market Share Purchases
Closing price · 2026-10-26: $12.85 · -2.58%
Telix Pharmaceuticals directors David Gill and William Jellison reported separate Nasdaq on-market purchases of American Depositary Shares, with no securities disposed. Gill’s holding rose from 22,000 to 25,250 ADS, while Jellison reported 25,000 ADS held jointly with Joanne Jellison.